On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Biomarkers provide a dynamic and powerful approach to understanding the spectrum of diseases from the earliest manifestations to the terminal stages. A recently published framework for the diagnosis of Alzheimer’s Disease (AD) in research studies would allow diagnosis on the sole basis of two biomarkers (-amyloid and tau). This revision will have substantial implications for future Alzheimer’s research. We will discuss the conditions that need to be met (validity, reliability, innovation) for this new diagnostic framework to foster identification of effective strategies to prevent or treat AD.
